Sun Pharmaceutical Industries Limited

NSE:SUNPHARMA.NS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

India

Market Cap

USD 47.07 B

Share Price

USD 19.71

Avg Daily Volume

2,429,017

Change (1 day)

-0.27%

Change (1 year)

-3.99%

Change (YTD)

-10.54%

Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2025: USD 1.65 B

Sun Pharmaceutical Industries Limited Operating Cash Flow is USD 1.65 B for the year ending March 31, 2025, a 13.19% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2024 was USD 1.45 B, a 141.11% change year over year.
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2023 was USD 603.40 M, a -49.01% change year over year.
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2022 was USD 1.18 B, a 40.42% change year over year.
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2021 was USD 842.69 M, a -3.12% change year over year.